Q-omics provides the consensus-scored HIGD1AP2 profile across patient tissues and cancer cell-line models. HIGD1AP2 expression is associated with patient survival in 9 of 34 cancer types, with the highest sampling consensus in KIRC. Additionally, HIGD1AP2 RNA expression shows 8,010 significant gene co-expression associations, with the highest sampling consensus in LIHC. Together, these results highlight KIRC, and LIHC as cancer lineages where HIGD1AP2 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.